Zyprexa remains on the market in the United States and more than 80 other countries. About 30 state attorneys general have subpoenaed documents detailing Lilly's sales practices for Zyprexa as part of a civil investigation under state consumer protection laws.
Zyprexa qualifies for a MedGuide warning:
(1) The labeling would definitely help prevent serious adverse events;
(2) Few patients would be willing to take the drug and risk developing diabetes given that numerous studies have shown Zyprexa to be no more effective than the older class of antipsychotics that do not cause diabetes; and
(3) Most patients on Zyprexa would learn that the drug is not FDA approved to treat the condition they have.
---
Daniel Haszard http://www.zyprexa-victims.com
HERE http://www.insideindianabusiness.com/newsitem.asp?ID=28308 Connecticut Sues Lilly Over Zyprexa (this is a RICO lawsuit like they use against organized crime)
